Table 2 Comparative analysis between the group of patients in whom elective and curative surgery was performed, and the group of patients in whom palliative and/or emergency surgery were carried out
Total | Elective and curative surgery 21 (52.5%) | Palliative and/or emergency surgery 19 (47.5%) | p | |
|---|---|---|---|---|
Age (mean ± SD) | 91.6 (± 1.5) | 91.5 (± 1.6) | 91.7 (±1.4) | 0.737 |
Gender | 0.427 | |||
Man | 13 (32%) | 8 (38.1%) | 5 (26.3%) | |
Woman | 27 (68%) | 13 (61.9%) | 14 (73.7%) | |
Institutionalized | 3 (7.5%) | 0 (0.0%) | 3 (15.8%) | 0.098 |
ASA | 0.874 | |||
I–II | 8 (20%) | 4 (19.0%) | 4 (21.1%) | |
III–IV | 32 (80%) | 17 (81.0%) | 15 (78.9%) | |
S-MPM | 0.031 | |||
I | 5 (13%) | 3 (14.3%) | 2 (10.5%) | |
II | 27 (67%) | 18 (85.7%) | 9 (47.4%) | |
III | 8 (20%) | 0 (0.0%) | 8 (42.1%) | |
Charlson Comorbidity Index | 0.065 | |||
No | 8 (20%) | 2 (9.5%) | 6 (31.6%) | |
Low | 11 (28%) | 5 (23.8%) | 6 (31.6%) | |
High | 21 (52%) | 14 (66.7%) | 7 (36.8%) | |
Neoplasm location | 0.061 | |||
Right sidea | 23 (58%) | 15 (71.4%) | 8 (42.1%) | |
Left side | 17 (42%) | 6 (28.6%) | 11 (57.9%) | |
Anastomosis | < 0.001 | |||
No | 18 (45%) | 3 (14.3%) | 15 /78.9%) | |
Yes | 22 (55%) | 18 (85.7%) | 4 (21.1%) | |
Transfusion | 0.055 | |||
No | 21 (53%) | 8 (38.1%) | 13 (68.4%) | |
Yes | 19 (47%) | 13 (61.9%) | 6 (31.6%) | |
TNM stage | 0.112 | |||
I–II | 28 (70%) | 17 (81.0%) | 11 (57.9%) | |
III–IV | 12 (30%) | 4 (19.0%) | 8 (42.1%) | |
CCI (median–IQR) | 22.6 (0.0–42.6) | 22.6 (10.5–34.1) | 12.2 (0.0–54.9) | 0.748 |
Operative mortality | 4 (10.0%) | 1 (4.8%) | 3 (15.8%) | 0.246 |
Median survival in months (IQR) | 26.8 (84.4–26.5) | 49.9 (99.8–19.1) | 17.5 (29.3–8.4) | 0.034 |